• Profile
Close

Survival in patients with parotid gland carcinoma – Results of a multi-center study

American Journal of Otolaryngology Nov 03, 2017

Honda K, et al. - During this research, the authors strived to update the clinical knowledge of parotid gland carcinoma by a multi-center approach. It was determined that the nodal metastases and high-grade histology served as significant negative prognostic factors for overall survival. The data suggested postoperative radiotherapy for patients with advanced high-grade carcinoma.

Methods

  • The Kyoto University Hospital and Affiliated Facilities Head and Neck Clinical Oncology Group (Kyoto-HNOG) carried out this research.
  • The enrollment consisted of 195 patients with parotid gland carcinoma who had been surgically treated with curative intent, recruited between 2006 and 2015 .
  • This study computed the clinical results including overall survival (OS), disease-free survival (DFS), disease-specific survival (DSS), local control rate (LCR), regional control rate (RCR), and distant metastasis-free survival (DMFS).
  • In order to determine the prognostic factors, univariate and multivariate analyses were carried out.

Results

  • The findings revealed that the median patient age was 63 years old (range 9-93 years), and the median observation period was 39 months.
  • It was noted that the OS, DFS, DSS, LCR, RCR, and DMFS at 3 years were 85%, 74%, 89%, 92%, 88%, and 87%, respectively.
  • Univariate analysis demonstrated a correlation between age over 74, T4, N+, preoperative facial palsy, high grade histology, perineural invasion, and vascular invasion with poor OS.
  • N+ and high grade histology served as independent factors in multivariate analysis.
  • Postoperative radiotherapy exhibited a connection with better OS in high risk patients, in subgroup analysis.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay